TrialPath
Recruiting

Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

NCT06551389 · University Hospital, Brest
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
Systemic lupus erythematosus is a complex systemicautoimmune disease that can affect most organs of the human body. Although they are many recommendations on the diagnosis and managment of SLE, diagnosis and therapeutic managment is still challenging. A pluridisciplinary consultation grouping rheumatologist, nephrologist, dermatologist, gynecologist, internist and immunologists has been set up in 2009 at the university hospital of Brest. The investigators would like to identify in a longitudinal cohort the occurrence of the different clinico-biological and immunological patterns of systemic lupus erythematosus patients during our multidisciplinary consultation. It is now crucial to organize a standardized data collection of these patients in order to evaluate our pratices, to be able to study the epidemiology of SLE in our city, and to promote this initiative at national and international level.
Eligibility criteria
Inclusion Criteria: * Any patient over 18 years old of the multidisciplinary consultation Exclusion Criteria: * Opposition of patient
Study design
Enrollment target: 300 participants
Age groups: adult, older_adult
Timeline
Starts: 2020-10-13
Estimated completion: 2035-04
Last updated: 2026-06-25
Primary outcomes
  • Cohort data (one year)
  • Cohort data (one year)
  • Cohort data (one year)
Sponsor
University Hospital, Brest · other
Contacts & investigators
ContactSandrine JOUSSE-JOULIN, Rheumatologist · contact · sandrine.jousse-joulin@chu-brest.fr · 33 (0)2-98-34-72-64
All locations (1)
CHRU de BrestRecruiting
Brest, France
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU · TrialPath